Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (AVHHL) EBIT Margin (2018 - 2025)

Historic EBIT Margin for AVITA Medical (AVHHL) over the last 8 years, with Q4 2025 value amounting to 11.31%.

  • AVITA Medical's EBIT Margin rose 942300.0% to 11.31% in Q4 2025 from the same period last year, while for Dec 2025 it was 29.14%, marking a year-over-year increase of 732400.0%. This contributed to the annual value of 46.23% for FY2025, which is 10139600.0% up from last year.
  • As of Q4 2025, AVITA Medical's EBIT Margin stood at 11.31%, which was up 942300.0% from 53.65% recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's EBIT Margin ranged from a high of 11.31% in Q4 2025 and a low of 154.95% during Q1 2024
  • Over the past 5 years, AVITA Medical's median EBIT Margin value was 70.63% (recorded in 2024), while the average stood at 78.61%.
  • As far as peak fluctuations go, AVITA Medical's EBIT Margin surged by 3290200bps in 2021, and later tumbled by -610100bps in 2024.
  • Over the past 5 years, AVITA Medical's EBIT Margin (Quarter) stood at 84.74% in 2021, then increased by 26bps to 62.49% in 2022, then plummeted by -38bps to 86.46% in 2023, then fell by -22bps to 105.54% in 2024, then skyrocketed by 89bps to 11.31% in 2025.
  • Its EBIT Margin stands at 11.31% for Q4 2025, versus 53.65% for Q3 2025 and 60.53% for Q2 2025.